Prevalence, Characteristics, and Molecular Epidemiology of Macrolide and Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae at Five Tertiary-Care Hospitals in Korea
Author(s) -
Jeong Hwan Shin,
Hee Jung Jung,
Hye Ran Kim,
Joseph Jeong,
Seok Hoon Jeong,
SunJoo Kim,
Eun Yup Lee,
Jeong Nyeo Lee,
Chulhun L. Chang
Publication year - 2007
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00107-07
Subject(s) - levofloxacin , streptococcus pneumoniae , microbiology and biotechnology , quinolone , erythromycin , streptococcus pyogenes , streptococcaceae , efflux , ofloxacin , antibacterial agent , biology , antibiotics , medicine , ciprofloxacin , bacteria , genetics , staphylococcus aureus
The genes erm(B), mef(A), and both erm(B) and mef(A) were identified in 42.6, 10.1, and 47.3%, respectively, of the erythromycin-resistant Streptococcus pneumoniae isolates. Of the strains, 3.8% were nonsusceptible to levofloxacin and had 1 to 6 amino acid changes in the quinolone resistance-determining region, including a new mutation, Asn94Ser, in the product of parC. Levofloxacin with reserpine was highly specific for efflux screening.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom